Tag: Tandem Diabetes Care

SAN DIEGO – Tandem Diabetes Care, has published the result of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The results, published in Diabetes Technology & Therapeutics demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people with Type 1 diabetes. People with the highest baseline blood sugar levels experienced the greatest...

DALLAS – Kam Yuricich has been named the 2023 Van Miller Homecare Champion for her achievements as the executive director for OAMES and the Great Lakes Home Medical Equipment Association.  Yuricich will be honored at the Stand Up For Homecare reception at Medtrade in Dallas on Wednesday, March 29.  “Kam is a star and a stalwart for HME,” says Tom Ryan, AAHomecare president and CEO. “She’s brought home bottom-line wins for her members and she’s also...

SAN DIEGO – Tandem Diabetes Care has announced the results from a prospective, multi-center, single-arm study of adults living with Type 2 diabetes who achieved improvement in all clinical endpoints with the use of the t:slim X2 insulin pump with Control-IQ technology. Data from the study, which was presented at the 22nd Annual Diabetes Technology Meeting, demonstrated the system to be safe during six weeks of use, with a substantial improvement in time in range and mean glucose related to...

SAN DIEGO – Tandem Diabetes Care has named Raj Sodhi, president of the software as a service (SaaS) business at ResMed, as an independent member of its board of directors effective Jan. 1. He brings to Tandem more than 25 years of digital strategy experience, SaaS commercialization and operations across multiple industries, including health care, financial services and telecom. “We are pleased to welcome Raj to our board of directors at this important next stage of Tandem’s...

SAN DIEGO - Tandem Diabetes Care reported sales increased to $66 million for the first quarter of 2019, a 142% over the same time period one year ago. Pump shipments increased from 4,444 to 14,732 during the same period, an increase of 232%. Gross profit for the quarter was $33.4 million compared to $11.4 million for the same quarter in 2018. “Our explosive growth in the first quarter was driven by strong domestic demand for the t:slim X2 insulin pump,” said John Sheridan, president and...

SAN DIEGO - Medical Device maker Tandem Diabetes Care has inked distribution agreements with Australasian Medical & Scientific Ltd (AMSL) and New Zealand Medical & Scientific Ltd (NZMS) to distribute Tandem's t:slim X2 Insulin Pump in Australia and New Zealand, respectively. “Partnering with key international distributors furthers our mission to expand available insulin pump choices for people with diabetes worldwide,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care....

SAN DIEGO - Tandem Diabetes Care, a manufacturer of touchscreen insulin pumps, has submitted a medical device license application to Health Canada to market its t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring integration. The company plans to launch the pump in Canada in the second half of 2018, subject to regulatory approvals. “This application is another important step toward achieving our strategic goal of bringing the benefits of the t:slim X2 Insulin Pump to...

LAKE FOREST, Calif. - Apria Healthcare will no longer file reports with the Securities and Exchange Commission (SEC), according to a Form-8K dated Jan. 21. Apria was obligated to file periodic reports with the SEC pursuant to the terms of indenture governing the company's outstanding 12.375% senior secured notes due 2014. On Jan. 16, however, the company provided a notice of redemption for all of its notes and effected a satisfaction and discharge of the company's obligation under the indenture....

SAN DIEGO - Tandem Diabetes Care is expanding the voluntary recall of certain lots of insulin cartridges used with the t:slim insulin pump, the company announced Jan. 20. The cartridges may leak, which could result in the pump delivering too much or too little insulin, according to the statement. “We are confident that we have identified all of the affected cartridge lots that may have been shipped to customers or distributors and that we have implemented appropriate corrective actions to prevent...